These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 22633033

  • 1. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial.
    Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, Anteunis LJ, van Breukelen GJ, Vlaeyen JW.
    Lancet; 2012 May 26; 379(9830):1951-9. PubMed ID: 22633033
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial.
    Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM.
    Lancet; 2012 Apr 14; 379(9824):1412-8. PubMed ID: 22385683
    [Abstract] [Full Text] [Related]

  • 3. Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial.
    Zipfel S, Wild B, Groß G, Friederich HC, Teufel M, Schellberg D, Giel KE, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, von Wietersheim J, Zeeck A, Schade-Brittinger C, Schauenburg H, Herzog W, ANTOP study group.
    Lancet; 2014 Jan 11; 383(9912):127-37. PubMed ID: 24131861
    [Abstract] [Full Text] [Related]

  • 4. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S.
    Health Technol Assess; 2000 Jan 11; 4(19):1-83. PubMed ID: 11086269
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of specialized treatment based on cognitive behavioral therapy versus usual care for tinnitus.
    Maes IH, Cima RF, Anteunis LJ, Scheijen DJ, Baguley DM, El Refaie A, Vlaeyen JW, Joore MA.
    Otol Neurotol; 2014 Jun 11; 35(5):787-95. PubMed ID: 24829038
    [Abstract] [Full Text] [Related]

  • 6. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
    van der Marck MA, Munneke M, Mulleners W, Hoogerwaard EM, Borm GF, Overeem S, Bloem BR, IMPACT study group.
    Lancet Neurol; 2013 Oct 11; 12(10):947-56. PubMed ID: 23988337
    [Abstract] [Full Text] [Related]

  • 7. Acceptance and commitment therapy versus tinnitus retraining therapy in the treatment of tinnitus: a randomised controlled trial.
    Westin VZ, Schulin M, Hesser H, Karlsson M, Noe RZ, Olofsson U, Stalby M, Wisung G, Andersson G.
    Behav Res Ther; 2011 Nov 11; 49(11):737-47. PubMed ID: 21864830
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of Internet-delivered cognitive behavior therapy and acceptance and commitment therapy in the treatment of tinnitus.
    Hesser H, Gustafsson T, Lundén C, Henrikson O, Fattahi K, Johnsson E, Zetterqvist Westin V, Carlbring P, Mäki-Torkko E, Kaldo V, Andersson G.
    J Consult Clin Psychol; 2012 Aug 11; 80(4):649-61. PubMed ID: 22250855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.
    van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA.
    Lancet Neurol; 2013 Nov 11; 12(11):1076-83. PubMed ID: 24090588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial.
    Prestmo A, Hagen G, Sletvold O, Helbostad JL, Thingstad P, Taraldsen K, Lydersen S, Halsteinli V, Saltnes T, Lamb SE, Johnsen LG, Saltvedt I.
    Lancet; 2015 Apr 25; 385(9978):1623-33. PubMed ID: 25662415
    [Abstract] [Full Text] [Related]

  • 15. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial.
    Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, McCrone P, Booth S, Jolley CJ, Moxham J.
    Lancet Respir Med; 2014 Dec 25; 2(12):979-87. PubMed ID: 25465642
    [Abstract] [Full Text] [Related]

  • 16. Internet-based guided self-help versus group cognitive behavioral therapy for chronic tinnitus: a randomized controlled trial.
    Jasper K, Weise C, Conrad I, Andersson G, Hiller W, Kleinstäuber M.
    Psychother Psychosom; 2014 Dec 25; 83(4):234-46. PubMed ID: 24970708
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH, Joore MA, Cima RF, Vlaeyen JW, Anteunis LJ.
    Ear Hear; 2011 Dec 25; 32(4):428-35. PubMed ID: 21221004
    [Abstract] [Full Text] [Related]

  • 19. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ, Mujakovic S, Fransen GA, Numans ME, de Wit NJ, Muris JW, van Oijen MG, Jansen JB, Grobbee DE, Knottnerus JA, Laheij RJ.
    Lancet; 2009 Jan 17; 373(9659):215-25. PubMed ID: 19150702
    [Abstract] [Full Text] [Related]

  • 20. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
    Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C.
    Lancet Oncol; 2012 Mar 17; 13(3):247-55. PubMed ID: 22341744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.